MGF (Mechano Growth Factor): Muscle Repair Peptide

Mechano Growth Factor (MGF) is not a foreign molecule — it is produced naturally in your own muscles every time you train hard enough to cause meaningful microtrauma. As a splice variant of IGF-1 generated in response to mechanical load and muscle damage, MGF has a specific, localized function: to activate the muscle satellite cells that reside quiescent between muscle fibers and set the repair and growth cascade in motion. Synthetic MGF, and its longer-acting pegylated version PEG-MGF, are used by researchers and some performance-oriented individuals to augment this natural process.

The Discovery of MGF

MGF was discovered by Geoffrey Goldspink and colleagues at University College London in the 1990s while studying how muscles respond to exercise and damage. They found that mechanical stimulation causes the IGF-1 gene to be spliced differently — producing MGF rather than systemic IGF-1 as the dominant product in the first hours after damage.

The key insight: MGF and systemic IGF-1, though both encoded by the same gene, have different biological roles. Systemic IGF-1 is a general anabolic hormone that circulates throughout the body. MGF is a local tissue repair signal that does not circulate significantly — it acts where it is produced, on the satellite cells in the damaged tissue.

How MGF Activates Muscle Repair

MGF acts on muscle satellite cells through a mechanism distinct from systemic IGF-1. The unique C-terminal sequence of MGF (the Ea peptide) is responsible for satellite cell activation. It binds to satellite cell surface receptors and triggers them to leave quiescence — becoming activated, proliferating, and eventually differentiating and fusing with damaged fibers.

This satellite cell activation is the prerequisite for muscle hypertrophy. Without sufficient satellite cell activation, muscle fibers cannot add the new myonuclei needed to support enlarged fiber volume. This is why MGF is particularly interesting for maximizing hypertrophic response to training and for recovery from significant muscle damage.

Time Window of Action

Natural MGF peaks in damaged muscle within 1-2 hours post-exercise and returns to baseline within 8-24 hours. This narrow time window is one reason synthetic MGF is used — it can be administered at the optimal post-exercise time to ensure robust satellite cell activation even when endogenous MGF production may be insufficient (aging, nutritional status, severe damage).

Dosing and Administration

Synthetic MGF is typically administered subcutaneously or intramuscularly in research protocols. Common doses are 100-200 mcg per muscle group, administered immediately or within 1-2 hours post-training. Intramuscular injection into the trained muscle is theoretically more targeted than subcutaneous administration.

Native MGF has a very short half-life — approximately 5-7 minutes in aqueous solution, as the C-terminal peptide is rapidly cleaved by enzymes. This extreme brevity limits its usefulness without modification.

Comparison to IGF-1 LR3

MGF and IGF-1 LR3 are complementary rather than interchangeable. In practice, many protocols use both: MGF immediately post-training (to activate satellite cells in the acute repair window), followed by IGF-1 LR3 later (to drive protein synthesis and support differentiation of activated satellite cells). This mirrors what happens physiologically: MGF spikes early post-exercise, followed by sustained IGF-1 elevation during recovery.

Limitations and Cautions

Human clinical data for MGF are essentially nonexistent. All evidence is from rodent studies or in vitro models. The safety profile in humans has not been characterized.

Like IGF-1, MGF carries theoretical concerns about mitogenic activity — stimulating cell proliferation in a non-selective manner that could theoretically promote cancer progression. This concern is theoretical but should not be dismissed without data.

FAQ

Does weight training naturally produce enough MGF? In young, healthy, well-nourished individuals with appropriate training loads, endogenous MGF is likely sufficient for normal muscle adaptation. The rationale for synthetic MGF is primarily for aging individuals (where satellite cell activation capacity declines), those recovering from injury, or those seeking accelerated adaptation beyond normal physiological capacity.

Can MGF be taken orally? No. Like all peptides, MGF is degraded by GI proteases and has essentially no oral bioavailability. Injection is required.

Is MGF on WADA's prohibited list? Yes, as a peptide hormone and growth factor. All IGF-1 splice variants are prohibited in competition.

Track your supplements in Optimize.